Source:http://linkedlifedata.com/resource/pubmed/id/16473885
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-4-3
|
pubmed:abstractText |
This investigation focused on obtaining a further understanding of the role of heme oxygenase-1 (HO-1) in tolerance induction. Hearts from C57BL/6 (H-2b) mice survived long-term when transplanted into BALB/c (H-2d) recipients treated with the tolerance-inducing regimen of anti-CD40L antibody (MR-1) plus donor-specific transfusion (DST). Grafts did not, however, survive long-term in (HO-1-/-) recipients given the same treatment. Similarly, long-term survival induced by DST was ablated when HO-1 activity was blocked by zinc protoporphyrin IX (ZnPPIX). We further asked whether modulation of HO-1 expression/activity could be used to promote the induction of graft tolerance. DST alone (day 0) failed to promote any prolongation of survival of DBA/2 (H-2d) hearts transplanted into B6AF1 (H-2(b,k/d)) recipients. However, long-term survival and (dominant peripheral) tolerance were readily induced when DST was combined with induction of HO-1 expression by cobalt protoporphyrin IX (CoPPIX). HO-1 induction plus DST led to a significant up-regulation of Foxp3, TGF-beta, IL-10, and CTLA4, which suggests a prominent role for CD4+CD25+ regulatory T cells (Tregs). In fact, the tolerogenic effect of HO-1 plus DST was dependent on CD4+CD25+ Tregs as suggested by adoptively transferring these cells into irradiated recipients under various regimens. Taken together, these findings show that expression of HO-1 in a graft recipient can be essential for long-term graft survival and for induction of tolerance and that modulation of HO-1 expression/activity can be used therapeutically to synergize in the generation of graft tolerance.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1530-6860
|
pubmed:author |
pubmed-author:BachFritz HFH,
pubmed-author:CsizmadiaEvaE,
pubmed-author:McDaidJamesJ,
pubmed-author:OllingerRobertR,
pubmed-author:SakahamaHideyasuH,
pubmed-author:SmithNeal RNR,
pubmed-author:SoaresMiguel PMP,
pubmed-author:TyagiShivrajS,
pubmed-author:WangHongjunH,
pubmed-author:YamashitaKenichiroK
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
776-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16473885-Animals,
pubmed-meshheading:16473885-Cells, Cultured,
pubmed-meshheading:16473885-Female,
pubmed-meshheading:16473885-Gene Deletion,
pubmed-meshheading:16473885-Gene Expression Regulation,
pubmed-meshheading:16473885-Heart Transplantation,
pubmed-meshheading:16473885-Heme Oxygenase-1,
pubmed-meshheading:16473885-Male,
pubmed-meshheading:16473885-Mice,
pubmed-meshheading:16473885-Mice, Inbred BALB C,
pubmed-meshheading:16473885-Mice, Inbred C57BL,
pubmed-meshheading:16473885-Protoporphyrins,
pubmed-meshheading:16473885-T-Lymphocytes,
pubmed-meshheading:16473885-Transplantation Tolerance
|
pubmed:year |
2006
|
pubmed:articleTitle |
Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs.
|
pubmed:affiliation |
Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|